<DOC>
	<DOCNO>NCT00120536</DOCNO>
	<brief_summary>The purpose study assess long term safety effectiveness three dos vildagliptin , unapproved drug , compare placebo lower overall blood glucose level people type 2 diabetes previously treat drug therapy lower blood sugar .</brief_summary>
	<brief_title>Efficacy Safety Three Doses Vildagliptin Drug Naive Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Vildagliptin</mesh_term>
	<criteria>Not currently drug therapy type 2 diabetes Blood glucose criterion must meet Body mass index ( BMI ) range 2245 History type 1 diabetes Evidence significant diabetic complication Serious cardiovascular event within past 6 month Laboratory value abnormality define protocol Other protocoldefined exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Type 2 diabetes</keyword>
	<keyword>vildagliptin</keyword>
</DOC>